InvestorsHub Logo
Followers 28
Posts 2529
Boards Moderated 0
Alias Born 05/08/2015

Re: HyGro post# 193617

Monday, 11/15/2021 11:22:44 AM

Monday, November 15, 2021 11:22:44 AM

Post# of 233148
So this is what you referred to as a "saline solution"?? LOL

The results indicated that from day zero to day seven, critically ill patients receiving leronlimab (on day zero) experienced a mortality rate 78% lower than patients receiving placebo.

Further, patients receiving the second dose of leronlimab achieved maximum benefit of 82% less mortality. However, the effects diminished from day 14 to day 21 and from day 21 to day 28, as the mortality rate decreased to 50% and 31%, respectively. The company believe it was due to patients not being administered leronlimab past day 7.


So you think a drug that failed to show it was any better than saline solution in two CoV clinical trials will save lives??


My comments are just my opinions and should NOT be taken as investment advice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News